AXT's Export Permit Timeline Will Either Validate the Rally or Expose It
AXT Inc (AXTI) reports first-quarter 2026 earnings tomorrow after market close, with analysts expecting continued losses but a significant improvement from the prior year. The central question is whether the compound semiconductor substrate maker can sustain the momentum from its Q3 2025 beat and demonstrate a credible path toward profitability as the industry recovers. With the stock up over 240% from its 200-day moving average and technical signals at maximum strength, investors face a critical test of whether recent optimism is justified by fundamental improvement.
Part 1: Earnings Preview
AXT Inc manufactures high-performance compound and single-element semiconductor substrate wafers, including indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge), serving markets where silicon substrates cannot meet performance requirements. The company operates manufacturing facilities in China and maintains partial ownership in ten raw material suppliers as part of its supply chain strategy.
AXT reports Q1 2026 earnings on April 30, 2026, after market close. Analysts expect an EPS loss of -$0.06 on revenue of approximately $26.74 million. The company most recently reported Q4 2025 earnings of -$0.08 per share. Compared to the same quarter last year when AXTI posted -$0.20 per share, the consensus estimate represents 70% improvement year-over-year, signaling analysts anticipate meaningful progress in the company's turnaround.
Three key themes define this earnings story:
Recovery in Substrate Demand: The semiconductor substrate market has shown signs of stabilization after a prolonged downturn. Investors will scrutinize whether AXTI is capturing improving demand in its core InP and GaAs markets, particularly from data center, 5G infrastructure, and optical networking applications. Revenue guidance and order book commentary will be critical indicators of whether the recovery has legs.
Path to Profitability: With losses narrowing significantly—from -$0.20 in Q1 2025 to an expected -$0.06 this quarter—the trajectory toward breakeven is the central narrative. Analysts project AXTI could reach $0.55 per share in 2027, representing a dramatic turnaround. Investors need to see evidence of operating leverage, improved gross margins, and cost discipline that supports this optimistic outlook.
China Manufacturing Exposure: AXTI's manufacturing footprint is concentrated in China, creating both cost advantages and geopolitical risks. Any commentary on supply chain resilience, tariff impacts, or customer diversification will be closely monitored, especially given heightened U.S.-China technology tensions.
Analyst sentiment heading into the release is constructive. The consensus maintains a Buy rating (4.00 average) with three Strong Buy recommendations balanced by three Hold ratings. The mean price target of $54.75 sits below the current trading level, but the high target of $90 suggests some analysts see substantial upside if execution continues to improve. The unchanged sentiment over the past month indicates analysts are waiting for this earnings report to validate or challenge their recovery thesis.
Part 2: Historical Earnings Performance
AXT's recent earnings history reveals an inconsistent pattern with two significant misses bracketing a notable beat. Over the past four quarters, the company has missed estimates twice and beaten twice, creating uncertainty about execution reliability.
The most recent quarter (Q4 2025) saw AXTI report -$0.08 versus the -$0.06 estimate, a 33.33% miss that disappointed investors. This followed a strong Q3 2025 performance where the company posted -$0.04 against expectations of -$0.13, delivering a 69.23% beat that demonstrated improving operational momentum. However, Q2 2025 brought another modest miss with -$0.16 versus -$0.15 expected (6.67% miss), and Q1 2025 saw a larger disappointment at -$0.20 versus -$0.15 (33.33% miss).
The pattern suggests AXTI is navigating a volatile recovery with uneven quarterly performance. While the Q3 beat demonstrated the company's potential when conditions align, the bookend misses in Q1 and Q4 indicate execution challenges remain. The magnitude of surprises has been meaningful—ranging from a 69% beat to 33% misses—suggesting either conservative guidance, demand volatility, or operational inconsistency. Investors should approach tomorrow's report with cautious optimism: the year-over-year improvement trend is clear, but quarter-to-quarter predictability has not yet been established.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $-0.15 | $-0.20 | -33.33% | Miss |
| Jun 2025 | $-0.15 | $-0.16 | -6.67% | Miss |
| Sep 2025 | $-0.13 | $-0.04 | +69.23% | Beat |
| Dec 2025 | $-0.06 | $-0.08 | -33.33% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
AXTI reports after market close, meaning Day 0 reflects anticipatory trading before results are known, while Day +1 captures the market's first full reaction to the actual earnings.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-19 | +$0.27 (+1.15%) | $2.03 (8.62%) | +$5.87 (+24.65%) | $6.01 (25.24%) |
| 2025-10-30 | +$0.25 (+3.54%) | $0.70 (9.90%) | +$0.63 (+8.61%) | $1.94 (26.50%) |
| 2025-07-31 | -$0.04 (-1.89%) | $0.19 (8.73%) | -$0.16 (-7.69%) | $0.26 (12.46%) |
| 2025-05-01 | -$0.05 (-3.57%) | $0.11 (7.86%) | +$0.04 (+2.96%) | $0.15 (11.16%) |
| 2025-02-20 | -$0.00 (-0.22%) | $0.34 (14.81%) | -$0.71 (-31.00%) | $0.39 (17.03%) |
| 2024-10-31 | -$0.18 (-6.70%) | $0.27 (9.78%) | -$0.47 (-18.06%) | $0.48 (18.72%) |
| 2024-08-01 | -$0.35 (-9.62%) | $0.29 (7.97%) | -$0.61 (-18.54%) | $0.48 (14.59%) |
| 2024-05-02 | +$0.14 (+4.84%) | $0.15 (5.19%) | +$0.63 (+20.79%) | $0.92 (30.36%) |
| Avg Abs Move | 3.94% | 9.11% | 16.54% | 19.51% |
Historical price behavior around AXTI earnings shows dramatic volatility with an average absolute Day +1 move of 16.54% and intraday ranges averaging 19.51%. The most recent earnings (February 2026) produced a 24.65% surge the following day after the Q3 beat, demonstrating how positive surprises can trigger explosive moves in this thinly-traded stock. Conversely, the February 2025 report triggered a 31.00% decline following a disappointing quarter.
The pattern is clear: AXTI exhibits outsized post-earnings reactions in both directions, with Day +1 moves consistently exceeding the Day 0 anticipatory trading. Six of the past eight reports produced Day +1 moves exceeding 10%, with four surpassing 18%. This volatility reflects the stock's small market capitalization, concentrated ownership, and the binary nature of investor sentiment around the turnaround story. Investors should prepare for significant price movement tomorrow—the historical average suggests a mid-teens percentage move is typical, but the range of outcomes is wide.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/01/26 (DTE 2) |
| Expected Move | $11.90 (16.74%) |
| Expected Range | $59.17 to $82.97 |
| Implied Volatility | 322.91% |
The options market is pricing a 16.74% expected move through Friday's expiration, slightly above the historical average Day +1 move of 16.54%. This suggests options traders are anticipating volatility consistent with recent history, though not at the extreme levels seen in the February 2026 report (24.65%) or February 2025 (-31.00%). The elevated implied volatility of 322.91% reflects significant uncertainty about the quarter's results and guidance.
Part 3: What Analysts Are Saying
Analyst sentiment on AXTI is constructive but divided. The consensus rating stands at 4.00 (Buy) with three Strong Buy recommendations balanced by three Hold ratings and no sell-side calls. This split reflects disagreement about the timing and magnitude of the company's recovery—bulls see a compelling turnaround story at an attractive entry point, while more cautious analysts want further proof of sustained improvement before upgrading.
The average price target of $54.75 sits approximately 23% below the current price of $71.07, suggesting the recent rally has outpaced analyst expectations. However, the wide target range—from a low of $28 to a high of $90—illustrates the divergent views on AXTI's prospects. The high target implies 27% upside from current levels if the company executes on its profitability roadmap, while the low target suggests significant downside risk if the recovery stalls.
Sentiment has remained unchanged over the past month, with no rating changes or target adjustments. This stability suggests analysts are in wait-and-see mode ahead of tomorrow's report. The lack of recent upgrades despite the stock's strong performance may indicate skepticism about sustainability, or simply that analysts are waiting for this quarter's results to validate the improving trend before revising models. Tomorrow's earnings and guidance will likely be the catalyst that either narrows the target range through upgrades or widens the divide if results disappoint.
Part 4: Technical Picture
AXTI enters earnings with maximum-strength technical momentum across all timeframes. The Barchart Technical Opinion shows a 100% Buy signal currently, unchanged from both one week and one month ago, indicating sustained bullish conviction throughout April.
Timeframe Analysis:
- Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum heading into the earnings event
- Medium-term (100% Buy): Strongest possible reading confirms the intermediate trend remains firmly bullish
- Long-term (100% Buy): Maximum long-term buy signal reflects a complete reversal from the prior downtrend
Trend Characteristics: The combination of Maximum strength and Strongest direction creates an exceptionally bullish technical environment, suggesting the stock has established a powerful uptrend with broad-based buying support across all timeframes.
The moving average structure confirms this bullish setup. AXTI trades above its 20-day ($66.55), 50-day ($53.89), 100-day ($36.27), and 200-day ($20.67) moving averages, demonstrating alignment across all major trend indicators. The stock sits slightly below its 5-day ($72.27) and 10-day ($76.64) averages, suggesting modest near-term consolidation after a strong run, but this minor pullback does not compromise the broader uptrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $72.27 | 50-Day MA | $53.89 |
| 10-Day MA | $76.64 | 100-Day MA | $36.27 |
| 20-Day MA | $66.55 | 200-Day MA | $20.67 |
The technical setup heading into earnings is overwhelmingly supportive, with the stock trading more than 240% above its 200-day moving average—an extraordinary extension that reflects either a fundamental re-rating or excessive optimism. Key resistance appears near the recent highs around $76, while support has developed at the 20-day moving average near $66. The challenge for bulls is that the stock has already priced in substantial improvement, leaving little room for disappointment. A beat-and-raise scenario could propel AXTI toward the $90 high analyst target, but any guidance caution could trigger profit-taking given the extended technical position. The maximum-strength buy signals suggest momentum remains intact, but the magnitude of the recent advance means volatility risk is elevated regardless of the fundamental outcome.